Alzheimer's disease: neurochemistry of Alzheimer's disease and its clinical implications

Author： Amaducci L.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 204-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selectivity of Cholinesterase Inhibition: Clinical Implications for the Treatment of Alzheimer’s Disease

By Weinstock M.  

CNS Drugs, Vol. 12, Iss. 4, 1999-10 ,pp. : 307-323

Adis International

Access to resources Recommend Favorite

Physiological Roles of Amyloid- and Implications for its Removal in Alzheimer’s Disease

By Glenda M. Bishop   Stephen R. Robinson  

Drugs & Aging, Vol. 21, Iss. 10, 2004-01 ,pp. : 621-630

Adis International

Access to resources Recommend Favorite

Review of rivastigmine and its clinical applications in Alzheimer’s disease and related disorders

By Desai A.   Grossberg G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Apolipoprotein E and Alzheimer’s Disease: Therapeutic Implications

By Higuchi M.  

CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

Neurogenesis in the Adult Brain: Implications for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 5, 2007-10 ,pp. : 303-310

Bentham Science Publishers

Access to resources Recommend Favorite